BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32079674)

  • 1. A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2).
    Damm-Ganamet KL; Rives ML; Wickenden AD; McAllister HM; Mirzadegan T
    J Biol Chem; 2020 Mar; 295(13):4359-4366. PubMed ID: 32079674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains.
    Mortensen OV; Liberato JL; Coutinho-Netto J; Dos Santos WF; Fontana AC
    J Neurochem; 2015 Apr; 133(2):199-210. PubMed ID: 25626691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2.
    Kato T; Kusakizako T; Jin C; Zhou X; Ohgaki R; Quan L; Xu M; Okuda S; Kobayashi K; Yamashita K; Nishizawa T; Kanai Y; Nureki O
    Nat Commun; 2022 Aug; 13(1):4714. PubMed ID: 35953475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2.
    Kortagere S; Mortensen OV; Xia J; Lester W; Fang Y; Srikanth Y; Salvino JM; Fontana ACK
    ACS Chem Neurosci; 2018 Mar; 9(3):522-534. PubMed ID: 29140675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.
    Butchbach ME; Tian G; Guo H; Lin CL
    J Biol Chem; 2004 Aug; 279(33):34388-96. PubMed ID: 15187084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures.
    Chen Y; Swanson RA
    J Neurochem; 2003 Mar; 84(6):1332-9. PubMed ID: 12614333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
    Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
    J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
    Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
    Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.
    Li Y; Sattler R; Yang EJ; Nunes A; Ayukawa Y; Akhtar S; Ji G; Zhang PW; Rothstein JD
    Neuropharmacology; 2011 Jun; 60(7-8):1168-75. PubMed ID: 21034752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.
    Dunlop J; Eliasof S; Stack G; McIlvain HB; Greenfield A; Kowal D; Petroski R; Carrick T
    Br J Pharmacol; 2003 Nov; 140(5):839-46. PubMed ID: 14517179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate transporter expression and function in human glial progenitors.
    Maragakis NJ; Dietrich J; Wong V; Xue H; Mayer-Proschel M; Rao MS; Rothstein JD
    Glia; 2004 Jan; 45(2):133-43. PubMed ID: 14730707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.
    Alijanpour S; Miryounesi M; Ghafouri-Fard S
    Metab Brain Dis; 2023 Jan; 38(1):1-16. PubMed ID: 36173507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons.
    Huang YH; Sinha SR; Tanaka K; Rothstein JD; Bergles DE
    J Neurosci; 2004 May; 24(19):4551-9. PubMed ID: 15140926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
    Jensen AA; Bräuner-Osborne H
    Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model.
    Falcucci RM; Wertz R; Green JL; Meucci O; Salvino J; Fontana ACK
    ACS Chem Neurosci; 2019 Aug; 10(8):3437-3453. PubMed ID: 31257852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate Transporters EAAT2 and EAAT5 Differentially Shape Synaptic Transmission from Rod Bipolar Cell Terminals.
    Tang FS; Yuan HL; Liu JB; Zhang G; Chen SY; Ke JB
    eNeuro; 2022; 9(3):. PubMed ID: 35523583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically Encoded Halide Sensor-Based Fluorescent Assay for Rapid Screening of Glutamate Transport and Inhibition.
    Zielewicz L; Grewer C
    ACS Sens; 2019 Sep; 4(9):2358-2366. PubMed ID: 31393114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.
    Lee SG; Su ZZ; Emdad L; Gupta P; Sarkar D; Borjabad A; Volsky DJ; Fisher PB
    J Biol Chem; 2008 May; 283(19):13116-23. PubMed ID: 18326497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches to enhance glutamate transporter function and expression.
    Fontana AC
    J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An amino-terminal point mutation increases EAAT2 anion currents without affecting glutamate transport rates.
    Kolen B; Kortzak D; Franzen A; Fahlke C
    J Biol Chem; 2020 Oct; 295(44):14936-14947. PubMed ID: 32820048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.